178
Participants
Start Date
January 17, 2023
Primary Completion Date
February 28, 2029
Study Completion Date
February 28, 2029
Vabametkib
"Tablets~Route of Administration: Oral"
Lazertinib
"Tablets~Route of Administration: Oral"
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
Taipei Veterans General Hospital, Taipei
RECRUITING
China Medical University Hospital, Taichung
RECRUITING
National Cheng Kung University Hospital, Tainan City
RECRUITING
Chi Mei Hospital, Liouying, Tainan City
RECRUITING
National Taiwan University Cancer Center (NTUCC), Taipei
RECRUITING
National Cancer Center, Goyang-si
RECRUITING
Seoul National University Bundang Hospital, Seongnam-si
RECRUITING
The Catholic University of Korea St Vincents Hospital, Suwon
RECRUITING
Ajou University Hospital, Suwon
RECRUITING
Gachon University Gil Medical Center, Incheon
RECRUITING
Chungbuk National University Hospital, Cheongju-si
NOT_YET_RECRUITING
The Henry Ford Cancer Institute, Detroit
RECRUITING
Gyeongsang National University Hospital, Jinju
RECRUITING
Cancer Care of North Florida, PA (Lake City Cancer Care, LLC) - Medical Oncology, Lake City
RECRUITING
Mid Florida Center, Orange City
RECRUITING
The University of Texas MD Anderson Cancer Center, Houston
RECRUITING
Boramae Medical Center, Dongjak
RECRUITING
Korea University Anam Hospital, Seoul
RECRUITING
Severance Hospital, Sinchon-dong
RECRUITING
Kangbuk Samsung Hospital, Seoul
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Samsung Medical Center, Seoul
RECRUITING
The Catholic University of Korea, Seoul St Mary's Hospitals, Seoul
Lead Sponsor
Abion Inc
INDUSTRY